Middletown, DE -- (SBWIRE) -- 09/11/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: A.P. Pharma, Inc.(OTCBB:APPA), Hercules Offshore, Inc.(NASDAQ:HERO), Merrimack Pharmaceuticals Inc(NASDAQ:MACK), Aastrom Biosciences Inc(NASDAQ:ASTM)
A.P. Pharma, Inc. (OTC:APPA) was a volume gainer of 1.95 million shares and the average volume of the stock remained 561,767.00 shares. The stock opened the session at $0.37 and finished at the end of the day at $0.360 and the stock plunged -7.69%.The market capitalization of the stock remained 110.51 million. The half-yearly trend of the stock remained negative -6.49%. A.P. Pharma, Inc., a specialty pharmaceutical company, engages in developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology. Its Biochronomer technology consists of bioerodible polymers designed to release drugs over a defined period of time.
Has APPA Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Hercules Offshore, Inc.(NASDAQ:HERO) exchanged 1.94 million shares and the average volume remained 2.13 million shares. The stock closed the session at $7.59 with the drop of -2.44%. Tracking three months and 6 months trends, the stock was at of +9.21% and +8.43%, respectively. Hercules Offshore, Inc., together with its subsidiaries, provides shallow-water drilling and marine services to the oil and natural gas exploration and production industry worldwide. The company operates through five segments: Domestic Offshore, International Offshore, Inland, Domestic Liftboats, and International Liftboats.
Why Should Investors Buy HERO After the Recent Fall? Just Go Here and Find Out
Merrimack Pharmaceuticals Inc(NASDAQ:MACK) decreased -2.75% and its closing price was $4.07. The volume of the stock was 1.93 million shares and the average volume remained 2.12 million shares. Yesterday, the stock traded amid the day price range of $4.00 - $4.20. The market capitalization of the stock remained 415.48 million. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States. The company uses its Network Biology proprietary systems biology-based approach to biomedical research.
Will MACK Get Buyers Even After The Recent Rally? Find Out Here
Aastrom Biosciences Inc(NASDAQ:ASTM) exchanged 1.90 million shares in the previous trading session, and its average trading remained 2.19 million shares. ASTM dropped -2.29% and it closed the trading at $0.320. The market capitalization of the stock remained 24.21 million. YTD trend of the stock was negative -74.8%. Aastrom Biosciences, Inc., a development stage company, engages in the development of patient-specific, cell products for use in the treatment of severe, chronic ischemic cardiovascular diseases. It is developing ixmyelocel-T, a patient-specific multicellular therapy expanded from a patient's own bone marrow and delivered directly to damaged tissues.
Has ASTM Found The Bottom and Ready To Move Up? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)